BDX

NYSE Becton, Dickinson and Company

Oct 28, 2026 · 5:52 AM ET LAST TRADE Market Closed

$198.59 ↑ +3.56 (+1.83%) Trading Up from the previous close of $195.03

YTD change: +2.33%
vs 20-day SMA: +5.58%
vs 200-day SMA: +16.95%

Price ranges

Previous day

$194.10 $196.16

open $194.77 close $195.03

+$0.26 (+0.13%)

Today

$0.00 $0.00

$198.59

Past week

$191.72 $200.47

from $193.80 now $198.59

+$4.79 (+2.47%)

Past month

$175.71 $200.47

from $181.97 now $198.59

+$16.62 (+9.14%)

This year

$140.11 $213.08

from $194.07 now $198.59

+$4.52 (+2.33%)

Price & Performance

+45.51 (+30.44%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 30.9% away from all-time highs of $287.32
BDX is up 2% since the beginning of the year
BDX is up 8% over the past 12 months
BDX is up 9% over the past 1 month
3% of all BDX investors are betting against BDX
Number of investors short BDX has gone down 17% versus last month

BDX reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +5.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $3.23

Earnings momentum +20.6% Quarterly EPS growth

Quarterly change +20.6%

Valuation

P/E ratio 59.91

Enterprise value $70.0B

Beta -0.16

Balance sheet & scale

Income$1.2M

Revenue$20.1B

Cash$864.0M

Debt$16.8M

Income / Debt 0.07×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Miscellaneous Manufacturing

Market cap $54.1B

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Competitor comparison

Ticker	Company	Price	Change
JNJ.CAT	JOHNSON & JOHNSON CDR CAD HEDGED	$34.25	+0.82%
DXCM	DexCom, Inc.	$78.56	-0.01%
MDLN	Medline, Inc. Class A	$32.38	-3.89%
WST	West Pharmaceutical Services, Inc.	$398.29	+0.90%
TRUMY	Terumo Corp Unsponsored ADR	$15.16	-1.30%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.